UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 210

Sortiert nach

Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients

Breast cancer research and treatment, 2007-10, Vol.105 (2), p.209-219

2007

Link zum Volltext

Verfügbarkeit prüfen

Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

Journal of clinical oncology, 2012-11, Vol.30 (32), p.3967-3975

2012

Link zum Volltext

Verfügbarkeit prüfen

HER2, TOP2A, and TIMP-1 and Responsiveness to Adjuvant Anthracycline-Containing Chemotherapy in High-Risk Breast Cancer Patients

Journal of clinical oncology, 2010-02, Vol.28 (6), p.984-990

2010

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction

Oral oncology, 2008-02, Vol.44 (2), p.162-173

2008

Link zum Volltext

Verfügbarkeit prüfen

Primary Tumor Levels of Tissue Inhibitor of Metalloproteinases-1 Are Predictive of Resistance to Chemotherapy in Patients with Metastatic Breast Cancer

Clinical cancer research, 2006-12, Vol.12 (23), p.7054-7058

2006

Link zum Volltext

Verfügbarkeit prüfen

Improvements in breast cancer survival between 1995 and 2012 in Denmark: The importance of earlier diagnosis and adjuvant treatment

Acta oncologica, 2016-06, Vol.55 Suppl 2 (sup2), p.24-35

2016

Link zum Volltext

Verfügbarkeit prüfen

The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women

European journal of cancer (1990), 2005-08, Vol.41 (12), p.1678-1689

2005

Link zum Volltext

Verfügbarkeit prüfen

Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients

Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 2008-08, Vol.106 (2), p.217-226

2008

Link zum Volltext

Verfügbarkeit prüfen

The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016

Acta oncologica, 2018-01, Vol.57 (1), p.13-18

2018

Link zum Volltext

Verfügbarkeit prüfen

Similar Efficacy for Ovarian Ablation Compared With Cyclophosphamide, Methotrexate, and Fluorouracil: From a Randomized Comparison of Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer

Journal of clinical oncology, 2006-11, Vol.24 (31), p.4956-4962

2006

Link zum Volltext

Verfügbarkeit prüfen

Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol

Acta oncologica, 2008, Vol.47 (4), p.672-681

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Intravenous Vinorelbine in Combination With Epirubicin Versus Epirubicin Alone in Patients With Advanced Breast Cancer: A Scandinavian Breast Group Trial (SBG9403)

Journal of clinical oncology, 2004-06, Vol.22 (12), p.2313-2320

2004

Link zum Volltext

Verfügbarkeit prüfen

Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer

Breast (Edinburgh), 2003-12, Vol.12 (6), p.516-521

2003

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial

Journal of clinical oncology, 2017-08, Vol.35 (23), p.2639-2646

2017

Link zum Volltext

Verfügbarkeit prüfen

The occurrence of fractures after adjuvant treatment of breast cancer: a DBCG register study

Acta oncologica, 2018-01, Vol.57 (1), p.141-145

2018

Link zum Volltext

Verfügbarkeit prüfen

Excess mortality in postmenopausal high-risk women who only receive adjuvant endocrine therapy for estrogen receptor positive breast cancer

Acta oncologica, 2014-02, Vol.53 (2), p.174-185

2014

Link zum Volltext

Verfügbarkeit prüfen

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

Acta oncologica, 2008, Vol.47 (4), p.506-524

2008

Link zum Volltext

Verfügbarkeit prüfen

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer

BMC cancer, 2009-06, Vol.9 (1), p.185-185

2009

Link zum Volltext

Verfügbarkeit prüfen

Letrozole in advanced breast cancer: the PO25 trial

Breast cancer research and treatment, 2007-01, Vol.105 Suppl 1 (S1), p.19-29, Article 19

Mouridsen, Henning T

2007

Link zum Volltext

Verfügbarkeit prüfen

Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women

Current medical research and opinion, 2006-08, Vol.22 (8), p.1609-1621

Mouridsen, Henning T.

2006

Link zum Volltext

Verfügbarkeit prüfen

Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer

JNCI : Journal of the National Cancer Institute, 2009-05, Vol.101 (10), p.729-735

2009

Link zum Volltext

Verfügbarkeit prüfen

Two years of tamoxifen or no adjuvant systemic therapy for patients with high-risk breast cancer: long-term follow-up of the Copenhagen breast cancer trial

Acta oncologica, 2018-01, Vol.57 (1), p.26-30

2018

Link zum Volltext

Verfügbarkeit prüfen

Danish Breast Cancer Cooperative Group - DBCG: History, organization, and status of scientific achievements at 30-year anniversary

Acta oncologica, 2008, Vol.47 (4), p.497-505

2008

Link zum Volltext

Verfügbarkeit prüfen

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

The Lancet (British edition), 1999-05, Vol.353 (9165), p.1641-1648

1999

Link zum Volltext

Verfügbarkeit prüfen

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

Breast cancer research and treatment, 2011-06, Vol.127 (2), p.345-355

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(194)

Publikationsform

Artikel
(210)

Sprache

Englisch
(200)
Japanisch
(30)
Dänisch
(8)
Russisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(151)
Female
(141)
Life Sciences & Biomedicine
(141)
Science & Technology
(141)
Oncology
(115)
Middle Aged
(89)
Biological And Medical Sciences
(88)
Medical Sciences
(88)
Breast Neoplasms - Drug Therapy
(82)
Aged
(72)
Adult
(67)
Tumors
(67)
Breast Neoplasms - Pathology
(56)
Breast Cancer
(55)
Gynecology. Andrology. Obstetrics
(52)
Mammary Gland Diseases
(51)
Breast Neoplasms - Mortality
(42)
Prognosis
(42)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(34)
Pharmacology. Drug Treatments
(34)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients

Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

HER2, TOP2A, and TIMP-1 and Responsiveness to Adjuvant Anthracycline-Containing Chemotherapy in High-Risk Breast Cancer Patients

Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction

Primary Tumor Levels of Tissue Inhibitor of Metalloproteinases-1 Are Predictive of Resistance to Chemotherapy in Patients with Metastatic Breast Cancer

Improvements in breast cancer survival between 1995 and 2012 in Denmark: The importance of earlier diagnosis and adjuvant treatment

The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women

Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients

The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016

Similar Efficacy for Ovarian Ablation Compared With Cyclophosphamide, Methotrexate, and Fluorouracil: From a Randomized Comparison of Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer

Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol

Phase III Study of Intravenous Vinorelbine in Combination With Epirubicin Versus Epirubicin Alone in Patients With Advanced Breast Cancer: A Scandinavian Breast Group Trial (SBG9403)

Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer

Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial

The occurrence of fractures after adjuvant treatment of breast cancer: a DBCG register study

Excess mortality in postmenopausal high-risk women who only receive adjuvant endocrine therapy for estrogen receptor positive breast cancer

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer

Letrozole in advanced breast cancer: the PO25 trial

Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women

Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer

Two years of tamoxifen or no adjuvant systemic therapy for patients with high-risk breast cancer: long-term follow-up of the Copenhagen breast cancer trial

Danish Breast Cancer Cooperative Group - DBCG: History, organization, and status of scientific achievements at 30-year anniversary

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

Suchergebnisse filtern